Moderators: Doubleday , al19
Search This Board: 
Created: 03/21/2011 02:54:55 AM - Followers: 182 - Board type: Free - Posts Today: 0
The Agrarian Group
https://www.himalayatechnologies.com/
On April 22, 2022 a third-party lender converted $4,675.07 of remaining debt including interest and penalties into 1,731,507 common shares eliminating all defaults on their note issued in 2014. Today we have 147,201,861 common shares outstanding, including 128,496,431free trading shares and 18,705,430 restricted shares. The Company now has no default debt.

 

Our business plan includes completing our social site Kanab.Club targeting health and wellness based in the cannabis market, generating revenues from advertising and subscriptions, incorporating social media site into the site, and marketing our planned 19.9% investment GenBio, Inc.’s health and wellness products targeting anti-inflammatory nutraceuticals to consumers. In the future, in partnership with GenBio, Inc., we plan to introduce a health and wellness energy and anti-inflammatory beverage product under the brand “FOMO” or other to drive growth. We are currently in discussions with co-pack and distribution companies, and GenBio, Inc. is formulating its extracts and obtaining laboratory certification for this planned consumer beverage.

 

 

On November 28, 2021 we issued 99,868 series B preferred shares of HMLA stock for 2,036,188 common shares of GENBIO Inc., representing 19.9% ownership. The GENBIO transaction is being accounted for as an investment on our balance sheet. We will not consolidate GENBIO’s financial statements.

 

 

On January 1, 2022, the Company signed a 19.9% stock purchase with The Agrarian Group LLC (“TAG”; , a provider of digital intelligence “AgtechDi” software designed from its granted patents to optimize the food supply chain by increasing food safety and profitability for growers who operate vertical farms, greenhouses, converted shipping containers, and other forms of controlled environment agriculture. Under the Investment Agreement, Himalaya is issuing TAG 99,686 Series B Preferred shares in exchange for 1,242,000 Class A Membership units of TAG. The transaction will be accounted for as an investment using a pre-money valuation for TAG of $10 million

 

 

KANAB CORP. is a development stage company targeting information services for the cannabis industry; we do not offer e-commerce services at this time and, given these matters, do not believe regulatory oversight or rules of law are a risk factor to our business.

 

We are in preliminary discussions with industry executives with contacts in the co-pack and distribution markets for canned and bottled beverages, though there can be assurances we will be successful in engaging any of these contacts for development of our pre-formulation pre-launch wellness beverage. Our planned beverage will not have any cannabis ingredients; it is derived from plum supplements and honey extracts sourced in South East Asia and Australia.

 

The Company has one wholly owned subsidiary, KANAB CORP. The Company has two investments, GenBio, Inc and The Agrarian Group, LLC. The Company owns 19.9% of GenBio and 19.9% of The Agrarian Group.

EXECUTIVE STATEMENT

 

GenBio Inc is an early-stage biotechnology company that researches novel therapeutics from a variety of extracts. GenBio has, based on recent USA research, created an Investigational New Drug (IND) research program from novel natural compounds that are highly effective as anti-inflammatory agents.

GenBio has secured the services of a director who has been involved and directed international research into rare extracts since 2010. He initially worked alongside the pioneering investigational scientific teams who made a major medical breakthrough with the natural extract; subsequently he amassed further research worldwide with other scientific teams also investigating specific properties for the same new, disruptive molecular platforms for pain relief, anti-inflammation and age-related healthcare issues.

In 2014, he was the first individual to bring the rare extract to the USA for further phytochemical research. The subsequent and completely unexpected scientific findings, which have global implications for medicine, means that it is imperative to take the extract through an Investigational New Drug Program (IND), then divest or license at IND Phase 1 inflexion point.

GenBio is led by a very highly experienced international executive team in this rare category and aims to be the first company in the world to isolate and fractionate core molecules based on its remarkable scientific findings from the USA.

 

OUR KEYS TO SUCCESS:

  • GenBio can build on the USA research breakthrough and rapidly develop a new class of inhibitors.
    GenBio has specialized scientific research teams ready to begin the IND research program once funds are secured.
    GenBio has significant confidential research expertise in this category, unrivalled by any competitor.
    GenBio will address a market gap with an entirely new generation of anti-inflammatory platforms and molecules with lower toxicity and increased efficacy due to multiple pathway targeting.
    SARS-CoV-19: GenBio Inc is fast tracking its proprietary NME and NCE that inhibits both the pathogens P. aeruginosa and Klebsiella pneumoniae – known bacteria associated with secondary infections that can cause significant lung infections and damage. The goal is to inhibit pathogens in the throat prior to spreading to the lungs. Our program will possibly be fast tracked under the ‘CTAP’ FDA program. Research in this area is critical and as a key support during future pandemics. 
    A second research program will focus on preventing a ‘cytokine storm’ and associated ‘flooding’ in the lungs. The research aims to develop an NME that both releases anti-inflammatory cytokines as well as suppress pro- inflammatory cytokines; this should decrease breathing difficulties in affected patients.
    Focused exit strategy within 36 months at IND inflexion point 1.
    Significant potential ROI based on conservative financial modelling.


The Agrarian Group

The Agrarian Group

Agricultural Technologies for a Growing Planet

 

Why

The Agrarian Group was started as an answer to a question - How will we feed the projected 9.1 Billion people that will reside on earth in 2050? To achieve this, we need to increase our already stressed agricultural production by 70%. How do we grow better?

The Problem

No question of this gravity is that simple. As a species, we face the most complex and deadly problems we have ever encountered. Erratic weather events caused by climate change destroy crop yields each year. Pesticides have ruined our soil and water scarcity has become a national security issue. 70% of food cost is linked to fossil fuels, and prices are only expected to rise. The average food item travels 1500 miles to reach it's destination. However, despite everything we do, 40% of all food in the United States is thrown away post-harvest. 

Values

 

Reduce Water Usage 

 

Reduce Need for Foreign Oil

 

Increase Food Safety

 

Create Local Food Systems

 

Increase Nutritional Value of Food

 

Benefit Local Communities

 

Economic Viability

Reduce Need for Pesticides

 

Increase Food Security

photo_434_20051109.jpgphoto_11602_20090601.jpgphoto_19242_20110109.jpg
photo_1515_20060501.jpg
 

What

The Agrarian Group specializes in Controlled Environment Agriculture (CEA). By controlling as many variables as possible through technology, automation, energy efficiency, and sustainable design, The Agrarian Group is able to provide end to end solutions for customers looking to grow premium quality produce. Through The Agrarian Group's CEA integrated systems and services allow for significant increases in yield and quality, at very low resource intensities. 

 

90%

Less Water Used

60% 

Increase in Grow times

1:48

Output Ratio per sq. ft. Compared to Traditional Agriculture

0

Dependence on Soil Conditions

99%

Reduction of Food Miles Possible

 
DSC_0001.JPG
DSC_0006.JPG
DSC_0024.JPG

 
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 2M
  • 3M
  • 6M
  • 1Y
  • 2Y
  • 3Y
  • 5Y
PlusOneCoin Top Posts Free PlusOneCoin
No plusone'd posts yet. Be the first!
Post Subject
#18480
HMLA Shareholders Updates https://finance.yahoo.com/news/himalaya-provides-share Doubleday 08/08/2022 01:17:11 PM
#18486
8k out also...this will fly soon. ace65 08/11/2022 03:44:32 PM
#18485
$HMLA annual list just filed, company is current Doubleday 08/11/2022 12:16:02 PM
#18484
Surprised at the low volume and some of ace65 08/09/2022 01:28:18 AM
#18483
I don’t know what happened to Grover. If cruecu 08/08/2022 03:37:53 PM
#18482
Great news out hope to see much more al19 08/08/2022 01:42:35 PM
#18481
$HMLA HIMALAYA PROVIDES SHAREHOLDER UPDATE ON GROWTH PORTFOLIO; BigJuan 08/08/2022 09:22:29 AM
#18480
HMLA Shareholders Updates https://finance.yahoo.com/news/himalaya-provides-share Doubleday 08/08/2022 09:17:11 AM
#18479
Good morning HMLA al19 08/04/2022 09:36:33 AM
#18478
Volume coming in today..just me here?...lol ace65 08/02/2022 10:44:50 AM
#18477
Its coming..added 200k today. ace65 07/29/2022 12:03:20 AM
#18476
Accumulation...every stock has it's day, it's about time. Doubleday 07/28/2022 08:07:30 PM
#18475
Interesting 8k out yesterday ace65 07/21/2022 08:52:59 AM
#18474
Yep GO $HMLA al19 07/19/2022 09:59:18 AM
#18473
Zzzzzzzzzzzzzzzzzzzz Doubleday 07/18/2022 04:55:28 PM
#18472
Watching and loading !!! >>>>>>>>>>>> al19 07/18/2022 01:41:22 PM
#18471
Grover has been giving a master class for cruecu 07/14/2022 02:49:03 PM
#18470
Looks like folks are throwing in the towel. Doubleday 07/14/2022 09:47:38 AM
#18469
Need news of some sort to stimulate buying. ace65 07/13/2022 11:20:45 AM
#18468
I agree would like to see progress, nice al19 07/13/2022 09:40:24 AM
#18467
That's great but this is the best that Doubleday 07/12/2022 02:29:06 PM
#18466
Much to come here CEO doesn't pump ...thats al19 07/12/2022 12:53:28 PM
#18465
Good morning HMLA al19 07/01/2022 09:47:49 AM
#18464
Great interview with a State representative for TAG, Doubleday 06/30/2022 09:54:54 AM
#18463
Smart move, it's just a matter of when Doubleday 06/30/2022 09:53:46 AM
#18462
I try and buy what I can every al19 06/30/2022 09:50:24 AM
#18461
Hoping to really be able to load up al19 06/30/2022 09:49:01 AM
#18460
SS still unchanged from April, no dilution here! Doubleday 06/30/2022 06:07:12 AM
#18459
Added another 100k today as well.Going to Pop ace65 06/29/2022 08:53:24 PM
#18458
Higher highs and higher lows, multiple pennies this Doubleday 06/29/2022 04:17:48 PM
#18457
Good morning $HMLA al19 06/29/2022 09:46:21 AM
#18456
Sounds good. If people say that enough, they’ll cruecu 06/29/2022 01:52:11 AM
#18455
Added today .Pop coming ace65 06/29/2022 01:51:24 AM
#18454
So it will do nothing since he’s already cruecu 06/28/2022 02:38:22 PM
#18453
This week as per IR on the Discord Doubleday 06/28/2022 10:48:34 AM
#18452
We have news coming? al19 06/27/2022 03:00:01 PM
#18451
I’ve seen the lack of volume and price cruecu 06/26/2022 01:38:29 AM
#18450
Exactly!!..gets jiggy on 1.2 million shares. ace65 06/26/2022 01:35:00 AM
#18449
It was like 6 grand cruecu 06/25/2022 12:07:29 AM
#18448
Nice trading today closed at high under pressure. ace65 06/24/2022 10:04:38 PM
#18447
As per the Discord channel, two PR's are Doubleday 06/24/2022 09:58:46 AM
#18446
Good morning $HMLA al19 06/24/2022 09:36:22 AM
#18445
lol back to current again... ace65 06/23/2022 09:30:04 AM
#18444
Back to Pink Current, absolutely lame! BigJuan 06/23/2022 08:47:05 AM
#18443
Agreed, It’s complete BS. They need to fix BigJuan 06/23/2022 08:46:36 AM
#18442
It will be current tomorrow, the otc markets Doubleday 06/22/2022 08:15:02 PM
#18441
Yet we are now Expert Market again??? WTF BigJuan 06/22/2022 07:30:55 PM
#18440
10Q is out, very clean. $HMLA Doubleday 06/22/2022 03:53:24 PM
#18439
UP 110% ...just me here lol ace65 06/17/2022 10:43:07 AM
#18438
Yes excellent to see.Should roll today. ace65 06/17/2022 08:34:09 AM
#18437
$HMLA Pink Current TB 06/17/2022 03:10:18 AM
Post Subject